ArriVent BioPharma’s Phase 3 lung cancer trial was clouded by stronger-than-expected data for patients receiving chemotherapy, prompting analysts to pivot focus to a late-stage test of the tyrosine ...

It’s been nine decades since Democrats won a Senate seat in this deep-red state. But there are signs that GOP Sen. Roger Marshall has a fight on his hands.

Here are the worldwide cybersecurity job openings available as of October 6, 2026, including on-site, hybrid, and remote ...

Samsung Electronics is expected to post Q3 operating profit near 106.1 trillion won, nearly nine times last year, as AI drives HBM chip demand.

Physical AI is moving beyond traditional automation as enterprises test robots for data center maintenance, manufacturing and ...

Grail received some excellent news from the FDA this week, but there's still a long way to go before the company meets ...

Luiz Inácio Lula da Silva barely leads Flavio Bolsonaro in Brazil election polls as analysts say the vote could reshape conservatism in the Americas.

Every day, brand-new airliners worth hundreds of millions of dollars take off, fly complex multi-hour flight paths, and land ...

In this four-part series, data analyst David Stasior argues that AI has made it possible to turn court and disciplinary ...

GLPI's 8.2% yield and WES's 8.1% distribution both clear the 5.18% Treasury, with coverage metrics showing AFFO of $4.10 to ...

<?xml encoding="utf-8" ?> Micron Technology, Inc. MU stock gained by more than 1% during Tuesday’s premarket session as ...

CIOs evaluating AI agent runtime controls need to know where those controls sit, what they can stop before execution and ...